(HealthDay News) — Overdiagnosis of thyroid cancer remains a persistent problem in the United States, researchers reported in The Lancet Diabetes & Endocrinology.
Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...
Health insurance doesn't cover preventative cancer screenings for firefighters and most municipalities don't pay for it ...
VIRGINIA BEACH, Va. — The overpass bridge on 264 over Rosemont Road could soon be named after a Virginia Beach firefighter ...
Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.
Ali Fedotowsky shared a photo of her husband Kevin Manno gearing up for surgery after receiving a thyroid cancer diagnosis ...
The American Cancer Society reports women 50 and under, now have an 82% higher risk of developing cancer than men.
Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.
Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...
In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.